{
    "2019-03-26": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Amid talk of buyout, Peninsula biotech zeroes in on its blood-thinner antidote",
                "features": {
                    "keywords": [
                        "buyout",
                        "Peninsula",
                        "biotech",
                        "blood-thinner",
                        "antidote"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie's Psoriasis Drug Skyrizi Gets First Approval in Japan",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Psoriasis",
                        "Skyrizi",
                        "approval",
                        "Japan"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Cyclacel Drops After Study Supporting Cancer Drug's Mechanism Of Action",
                "features": {
                    "keywords": [
                        "Cyclacel",
                        "drops",
                        "study",
                        "cancer",
                        "drug",
                        "mechanism",
                        "action"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}